Cosan (CSAN3) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
28 Aug, 2026Corporate structure and segment definition
Corporate structure includes senior management, corporate teams, equity results, and financial results from parent and intermediate holdings, including offshores.
Cosan Dez was incorporated into the Corporate segment from 4Q23, improving result comparability.
Holdings include Cosan Nove, Cosan Dez, and several offshore entities.
Sources of cash and capital
Main cash sources are dividends from subsidiaries, divestments, and new funding (debt and equity).
Consistent dividend inflows from subsidiaries, with R$3.5bn net dividends in 2024.
Significant divestments include sales of VALE3 shares and Radar's properties, optimizing capital structure.
Multiple debt issuances and bond offerings have optimized maturity, cost, and liquidity.
Equity fundraising through preferred shares at intermediate holdings, with flexible structures and renegotiations to reduce funding costs.
Uses of cash and capital allocation
Uses include debt amortization, interest payments, G&A expenses, acquisitions, buybacks, and dividends.
Early redemption of several debt issuances and bonds, and share buybacks totaling ~R$1.1bn in 2024.
G&A and other expenses totaled R$461mn in 2024, with tax impacts mainly from asset sales and financial revenues.
Dividend policy mandates at least 25% of adjusted net income distributed annually; no dividends in 2025 and 6M26.
Latest events from Cosan
- Net loss improved to R$320 million and net debt dropped 47% YoY, aided by divestments and IPO.CSAN3
Q2 2026 - Net loss narrowed to R$1.6 billion, with strong EBITDA and major deleveraging actions.CSAN3
Q1 2026 - EBITDA and net income fell, but major asset sales and capital raises improved leverage and liquidity.CSAN3
Q4 2025 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 2025 - EBITDA fell to R$6.0bn, net loss widened, and leverage rose to 3.4x as segment results diverged.CSAN3
Q2 2025 - EBITDA rose, net income fell, and management changes and acquisitions shaped the quarter.CSAN3
Q3 2024 - EBITDA rose 15% to R$7.1bn, net loss narrowed, and capital discipline remained strong.CSAN3
Q2 2024 - Net loss reached R$1.8B, EBITDA fell 30%, but net debt dropped to R$17.5B after asset sales.CSAN3
Q1 2025 - Net revenue rose 11%, but large impairments led to a R$9.4 billion net loss in 2024.CSAN3
Q4 2024